Challenges and choices in drug therapy for chronic pain

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 2, 2003, Pages 119-138

  Fishman, Scott M ^a   Teichera, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CAPSAICIN; CELECOXIB; CLOMIPRAMINE; CLONIDINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROMETHORPHAN; DEXTROMETHORPHAN PLUS MORPHINE; DEXTROPROPOXYPHENE; DICLOFENAC; DOXEPIN; FENTANYL; IBUPROFEN; KETAMINE; METHADONE; MORPHINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; PARACETAMOL; PETHIDINE; ROFECOXIB; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; CARDIOTOXICITY; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG PREFERENCE; HUMAN; LONG TERM CARE; NEUROPATHIC PAIN; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PRESCRIPTION; QUALITY OF LIFE; REVIEW; SEDATION; SEXUAL DYSFUNCTION; STOMACH HEMORRHAGE; SUSTAINED RELEASE FORMULATION; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

EID: 0037295014     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.2.119     Document Type: Review

References (29)

1. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105(suppl 1B):31S-38S.
2. McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs 1991; 41:533-547.
3. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992; 19:1950-1954.
4. Cooper SA. The relative efficacy of ibuprofen in dental pain. Compendium of Continuing Education in Dentistry 1986; 7(8):578-588.
5. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther 1999; 66:625-635.
6. Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci USA 1999; 96:3275-3280.
7. AHCPR Publication No. 94-0593. Rockville, MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, March 1994.
8. Ready LB, Sarkis E, Turner JA. Self-reported vs actual use of medications in chronic pain patients. Pain 1982; 12:285-294.
9. Porter J, Jick H. Addiction rare in patients treated with narcotics [letter]. N Engl J Med 1980; 302:123.
10. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Sympt Manage 1990; 5:S46-S62.
11. Hill CS Jr. Relationship among cultural, educational, and regulatory agency influences on optimum cancer pain treatment. J Pain Sympt Manage 1990; 5(suppl 1):S37-S45.
12. Vallerand AH. Street addicts and patients with pain: similarities and differences. Clin Nurse Specialist 1994; 8(1):11-15.
13. McNairy SL, Maruta T, Ivnik RJ, Swanson DW, Ilstrup DM. Prescription medication dependence and neuropsychologic function. Pain 1984; 18:169-177.
14. Rathmell JP, Jamison RN. Opioid therapy for noncancer pain. Curr Opin Anaesthesiol 1996; 9:436-442.
15. Fordyce WE. Behavioral concepts in chronic pain and illness. In: Davidson PO, editor: The Behavioral Management of Anxiety, Depression and Pain. New York: Brunner/Mazel, 1975:147-188.
16. Brena SF, Sanders SH. Opioids in nonmalignant pain: questions in search of answers. Clin J Pain 1991: 7:342-345.
17. McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Therapeut 2001; 8:181-186.
18. Melzack R. IASP Presidential Address. The tragedy of needless pain: a call for social action. In: Dubner R, Gebbart MR, Bond MR, editors. Proceedings of the 5th World Congress of Pain. New York: Elsevier, 1988:1-11.
19. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Sympt Manage 1996; 11:163-171.
20. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-1841.
21. Bennett GJ. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Sympt Manage 2000; 19(suppl 1):S2-S6.
22. McQuay HJ, Carroll D, Jadad AR, Glynn CJ, Jack T, Moore RA, Wiffeh PJ. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994; 59:127-133.
23. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48:1212-1218.
24. Yamakura T, Sakimura K, Shimoji K. Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids. Anesthesiology 1999; 91:1053-1063.
25. Katz NP. MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients. J Pain Sympt Manage 2000; 19(suppl S):S37-S41.
26. Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Sympt Manage 1999; 18:27-37.
27. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83:389-400.
28. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypothesis of gabapentin pharmacology. Epilepsy Res 1998, 29:233-239.
29. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000; 19 (suppl): 516-520.